For UK healthcare professionals
Chairs: June James and Debbie Hicks
Speaker: Prof Ramzi Ajjan
Professor of Metabolic Medicine/Consultant in Diabetes and Endocrinology
University of Leeds and Leeds Teaching Hospitals NHS Trust
Prof Ajjan shall present the evidence for use of CGM in Type 2 diabetes, covering NICE guidance, patient selection. Clinical outcomes of use of CGM in Type 2 diabetes, hypoglycaemia reduction, improved Time in Range.
At the end of this session, you will have learned about:
1. Understanding of the clinical evidence for the use of CGM in Type 2 diabetes
2. When and how to initiate CGM in the person with Type 2 diabetes
3. Understanding the data to improve clinical outcomes
This webinar is sponsored by an educational grant from Abbott Laboratories Ltd.
Register here.